Glutathione S-transferase M1 (GSTM1) genotype but not GSTT1 or MC1R genotype influences erythemal sensitivity to narrow band (TL-01) UVB phototherapy

Pharmacogenetics and Genomics

Volumn 21, Issue 4, 2011, Pages 217-224

  Smitha, Gillian ^a   Weidlicha, Simone ^a   Daweb, Robert S ^a   Ibbotsonb, Sally H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Erythema; Genotype; Gstm1; GSTT1; MC1R; Phototherapy; Polymorphism; TL 01; Ultraviolet radiation

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MELANOCORTIN 1 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ERYTHEMA; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; SKIN SENSITIVITY; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

EID: 79955463366     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32833efb36     Document Type: Article

References (53)

1. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ.Prevalence and treatment of psoriasis in the United Kingdom: a populationbased study. Arch Dermatol 2005; 141:1537-1541. (Pubitemid 41815843)
2. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB,et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 2010;62:114-135.
3. Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, et al.A randomized controlled trial of narrowband ultraviolet B vs. bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003;148:1194-1204. (Pubitemid 36819220)
4. Ibbotson SH, Bilsland D, Cox NH, Dawe RS, Diffey B, Edwards C, et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004;151:283-297. (Pubitemid 39215142)
5. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01)ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol 1998; 138:833-839. (Pubitemid 28231525)
6. Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 2004; 43:326-335. (Pubitemid 38714593)
7. Marrot L, Meunier JR. Skin DNA photodamage and its biological consequences. J Am Acad Dermatol 2008; 58:S139-S148. (Pubitemid 351503640)
8. Gruber F, Mayer H, Lengauer B, Mlitz V, Sanders JM, Kadl A, et al.NF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells. FASEB J 2010; 24:39-48.
9. Marrot L, Jones C, Perez P, Meunier JR. The significance of Nrf2 pathway in (photo)-oxidative stress response in melanocytes and keratinocytes of the human epidermis. Pigment Cell Melanoma Res 2008; 21:79-88. (Pubitemid 351421462)
10. Tyrrell R. Redox regulation and oxidant activation of heme oxygenase-1.Free Radic Res 1999; 31:335-340. (Pubitemid 29452859)
11. Tyrrell RM, Reeve VE. Potential protection of skin by acute UVA irradiation-from cellular to animal models. Prog Biophys Mol Biol 2006;92:86-91. (Pubitemid 43831965)
12. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45:51-88. (Pubitemid 40261798)
13. Dourado DF, Fernandes PA, Ramos MJ. Mammalian cytosolic glutathione transferases. Curr Protein Pept Sci 2008; 9:325-337.
14. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on transstilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 1988;85:7293-7297.
15. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM,et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-276. (Pubitemid 24151046)
16. Leite JL, Morari EC, Granja F, Campos GM, Guilhen AC,Ward LS. Influence of the glutathione S-transferase gene polymorphisms on the susceptibility to basal cell skin carcinoma. Rev Med Chil 2007; 135:301-306.
17. Lira MG, Provezza L, Malerba G, Naldi L, Remuzzi G, Boschiero L, et al.Glutathione S-transferase and CYP1A1 gene polymorphisms and nonmelanoma skin cancer risk in Italian transplanted patients. Exp Dermatol 2006; 15:958-965. (Pubitemid 44688366)
18. Kerb R, Brockmoller J, Reum T, Roots I. Deficiency of glutathione S-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol 1997; 108:229-232. (Pubitemid 27061038)
19. Kerb R, Brockmoller J, Schlagenhaufer R, Sprenger R, Roots I, Brinkmann U,et al. Influence of GSTT1 and GSTM1 genotypes on sunburn sensitivity.Am J Pharmacogenomics 2002; 2:147-154. (Pubitemid 34839446)
20. Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C.Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 2005; 18:393-410. (Pubitemid 41691455)
21. Healy E, Jordan SA, Budd PS, Suffolk R, Rees JL, Jackson IJ. Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 2001;10:2397-2402. (Pubitemid 33069545)
22. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995; 11:328-330.
23. Kadekaro AL, Kavanagh R, Kanto H, Terzieva S, Hauser J, Kobayashi N, et al. Alpha-melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 2005;65:4292-4299. (Pubitemid 40775668)
24. Bohm M, Wolff I, Scholzen TE, Robinson SJ, Healy E, Juger TA, et al.Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 2005; 280:5795-5802. (Pubitemid 40280060)
25. Smith G, Wilkie MJ, Deeni YY, Farr PM, Ferguson J, Wolf CR, et al.Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy. Br J Dermatol 2007; 157:1230-1234. (Pubitemid 350115686)
26. Kerb R, Brockmoller J, Sachse C, Roots I. Detection of the GSTM1.*0allele by long polymerase chain reaction. Pharmacogenetics 1999;9:89-94. (Pubitemid 29177997)
27. Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, Roots I,et al. Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 2000;10:557-565.
28. McLellan RA, Oscarson M, Alexandrie AK, Seidegard J, Evans DA,Rannug A, et al. Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity. Mol Pharmacol 1997; 52:958-965. (Pubitemid 28013713)
29. Cameron H, Dawe RS, Yule S, Murphy J, Ibbotson SH, Ferguson J.A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis.Br J Dermatol 2002; 147:973-978. (Pubitemid 35365446)
30. Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett CJ, et al.Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility.Carcinogenesis 1991; 12:1533-1537.
31. Mossner R, Anders N, Konig IR, Kruger U, Schmidt D, Berking C, et al.Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch Dermatol Res 2007; 298:371-379. (Pubitemid 44912440)
32. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J.The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009; 29:3511-3536.
33. Welsh MM, Applebaum KM, Spencer SK, Perry AE, Karagas MR,Nelson HH. CTLA4 variants, UV-induced tolerance, and risk of nonmelanoma skin cancer. Cancer Res 2009; 69:6158-6163.
34. Applebaum KM, Karagas MR, Hunter DJ, Catalano PJ, Byler SH, Morris S,et al. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ Health Perspect 2007; 115:1231-1236. (Pubitemid 351802357)
35. Heitzer E, Lassacher A, Quehenberger F, Kerl H,Wolf P. UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype. J Invest Dermatol 2007; 127:2872-2881. (Pubitemid 350134820)
36. Fryer AA, Ramsay HM, Lovatt TJ, Jones PW, Hawley CM, Nicol DL, et al.Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients. Carcinogenesis 2005; 26:185-191. (Pubitemid 40207714)
37. Ramsay HM, Harden PN, Reece S, Smith AG, Jones PW, Strange RC,et al. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients:a preliminary analysis. J Invest Dermatol 2001; 117:251-255. (Pubitemid 34205708)
38. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, et al.Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009; 41:920-925.
39. Duffy DL, Zhao ZZ, Sturm RA, Hayward NK, Martin NG, Montgomery GW.Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J Invest Dermatol 2010; 130:520-528.
40. Ollier W, Davies E, Snowden N, Alldersea J, Fryer A, Jones P, et al.Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro + /La- autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:1763-1764. (Pubitemid 26331034)
41. Saadat M, Farvardin-Jahromi M. Occupational sunlight exposure, polymorphism of glutathione S-transferase M1, and senile cataract risk.Occup Environ Med 2006; 63:503-504. (Pubitemid 43974034)
42. Guarneri F, Asmundo A, Sapienza D, Gazzola A, Cannavo SP. Polymorphism of glutathione S-transferases M1 and T1: susceptibility to solar keratoses in an Italian population. Clin Exp Dermatol 2009. [Epub ahead of print]
43. Steinberg ML, Hubbard K, Utti C, Clas B, Hwang BJ, Hill HZ, et al.Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients. Photochem Photobiol 2009; 85:379-386.
44. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.Carcinogenesis 2005; 26:1263-1271. (Pubitemid 41417904)
45. Scherer D, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Hemminki K,et al. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. Int J Cancer 2008; 122:1787-1793. (Pubitemid 351413425)
46. Liboutet M, Portela M, Delestaing G, Vilmer C, Dupin N, Gorin I, et al.MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J Invest Dermatol 2006; 126:1510-1517.
47. Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159:931-935.
48. Moffat GJ, McLaren AW, Wolf CR. Involvement of Jun and Fos proteins in regulating transcriptional activation of the human pi class glutathione S-transferase gene in multidrug-resistant MCF7 breast cancer cells. J Biol Chem 1994; 269:16397-16402.
49. Chanas SA, Jiang Q, McMahon M, McWalter GK, McLellan LI, Elcombe CR, et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 2002; 365:405-416. (Pubitemid 36135312)
50. McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001; 61:3299-3307. (Pubitemid 32695017)
51. Hayes JD, Chanas SA, Henderson CJ, McMahon M, Sun C, Moffat GJ, et al. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans 2000; 28:33-41. (Pubitemid 30103209)
52. Hauser JE, Kadekaro AL, Kavanagh RJ, Wakamatsu K, Terzieva S,Schwemberger S, et al. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res 2006; 19:303-314. (Pubitemid 44015593)
53. Scott MC, Wakamatsu K, Ito S, Kadekaro AL, Kobayashi N, Groden J, et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci 2002; 115:2349-2355. (Pubitemid 34752978)